Efficacy of Osteogenic Protein-1 in a Challenging Multilevel Fusion Model

Spine

Volumn 29, Issue 3, 2004, Pages 249-256

  Mermer, Matthew J ^a   Gupta, Munish C ^a   Wheeler, Donna L ^b   Helgerson, Joel ^b   Reddi, A Hari ^a   Hazelwood, Scott ^a   Benson, Daniel R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Chemical and Biological Engineering and School of Biomedical Engineering   (United States)

Author keywords

Bone morphogenic proteins; Multiple level spine fusion; Osteogenic protein 1

Indexed keywords

CARBOXYMETHYLCELLULOSE; COLLAGEN TYPE 1; OSTEOGENIC PROTEIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BIOMECHANICS; BONE GRAFT; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; SHEEP; SPINE FUSION; SPINE SURGERY;

ANIMALS; BIOMECHANICS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; FEMALE; LUMBAR VERTEBRAE; SHEEP; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0742322215     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.BRS.0000109994.36349.D7     Document Type: Article

References (20)

1. Cotler JM, Star AM. Complications of spinal fusions. In: Cotler JM, Cotler HB, eds. Spinal Fusion: Science and Technique. New York, NY: Springer-Verlag; 1990:361-87.
2. Sandhu HS, Kanim LEA, Kabo JM, et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 1995;20:2669-82.
3. Steinmann JC, Herkowitz N. Pseudoarthrosis of the spine. Clin Orthop 1992;284:80-90.
4. Summers BN, Eisenstein SM. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 1989;71:677-80.
5. Cook SD, Rueger DC. Osteogenic protein-1: biology and applications. Clin Orthop 1996;324:29-38.
6. Cook SD, Dalton JE, Tan EH, et al. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 1994;19:1655-63.
7. Minamide A, Tamaki T, Kawakami M, et al. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. Spine 1999;24:1863-72.
8. Boden S, Zdeblick T, Sandhu H, et al. Spine 2000;25:376-381.
9. Guigui P, Plais PY, Flautre B, et al. Experimental model of posterolateral spinal arthrodesis in sheep. Spine 1994;19:2791-7.
10. Lenke L, Bridwell KH. Adult spondylolisthesis with lysis. In: Bridwell KH, DeWald R, eds. The Textbook of Spinal Surgery. Philadelphia, PA: Lippincott-Raven; 1997:1269-98.
11. Deguchi M, Rapoff AJ, Zdeblick T. Posterolateral fusion for isthmic spondylolisthesis in adults: analysis of fusion rates and clinical results. J Spinal Disord 1998;11:459-64.
12. Zdeblick T. A prospective, randomized study of lumbar fusion. Preliminary results. Spine 1993;18:983-91.
13. Boden S, Schimandle J. Biologic enhancement of spinal fusion. Spine 1995;20:113S-23S.
14. Boden S, Sumner D. Biologic factors affecting spinal fusion and bone regeneration. Spine 1995;20:102S-112S.
15. Boden S, Schimandle M, Hutton W, et al. The use of an osteoinductive growth factor for lumbar spinal fusion. Part I: Biology of spine fusion. Spine 1995;20:2626-32.
16. Boden S, Schimandle M, Hutton W. The use of an osteoinductiove growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine 1995;20:2633-44.
17. Cunningham BW, Kanayama M, Parker L, et al. Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. Spine 1999;24:509-18.
18. Muschler G, Hyodo A, Manning T, et al. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 1994;308:229-40.
19. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2). Spine 1995;20:1326-37.
20. Kotani Y, Cunningham BW, Cappuccino A, et al. The role of spinal instrumentation in augmenting lumbar posterolateral fusion. Spine 1996;21:278-87.